BRIEF-Xylem Q4 Revenue USD 2,400 Million Vs. IBES Estimate USD 2,374 Million

Reuters
Feb 10
BRIEF-Xylem Q4 Revenue USD 2,400 Million Vs. IBES Estimate USD 2,374 Million

Feb 10 (Reuters) - Xylem Q4 adjusted EPS USD 1.42 vs. IBES estimate USD 1.41.

  • Q4 adjusted net income USD 348 million vs. IBES estimate USD 341.5 million
  • Q4 EPS USD 1.37
  • outlook FY revenue USD 9,100-9,200 million
  • outlook FY adjusted EPS USD 5.35-5.6
  • outlook FY adjusted EBITDA margin 22.9-23.3%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10